Showing 7,404 results

Filters Content type: News, Editors' picks Country: North America
Retention & linkage to care

Cash Incentives, Peer Support May Not Incentivize HCV Treatment

Editor's pick
MD Magazine
10 May 2019
Pharmaceutical industry

Gilead Will Donate Truvada to U.S. for H.I.V. Prevention

Editor's pick
The New York Times
10 May 2019
Harm reduction

If Canada can open 50 drug consumption rooms to save lives, why not Scotland?

Editor's pick
Transform
9 May 2019
PrEP programmes & uptake

Generic HIV prevention drug coming in 2020, Gilead says

Editor's pick
CNBC
9 May 2019
PrEP programmes & uptake

Official Statement responding to Gilead Sciences’ announcement that it will allow Teva to Manufacture a Generic Version of Truvada

Editor's pick
Breakthepatent.org
9 May 2019
PrEP policies & guidelines

PrEP 2-1-1 offered at Magnet, San Francisco

Editor's pick
BETA blog
8 May 2019
Starting treatment

Immediate HIV treatment initiation has improved but not yet universal in NYC, study finds

Editor's pick
News-Medical.net
7 May 2019
PrEP policies & guidelines

How About Letting Nurses Provide PrEP to Patients?

Editor's pick
Contagion Live
3 May 2019
Epidemiology & behaviour

How does condom use change over time as young MSM get older?

News
3 May 2019
PrEP policies & guidelines

US: Health care providers split on who should prescribe HIV prevention drug

Editor's pick
Eurekalert Inf Dis
1 May 2019
Young people

PrEP vs. Privacy

Editor's pick
Slate
29 April 2019
Combatting stigma

Rep. Brian Sims on Taking HIV Prevention Drug: 'The Shaming Around PrEP Is Akin to Shaming Women on the Pill'

Editor's pick
Newsweek
26 April 2019
Activism & civil society

How Activists Uncovered CDC's Ownership of Truvada PrEP Patents

Editor's pick
The Body
25 April 2019
HIV & criminal law

New Policy for British Columbia Prosecutors Still Harms People Living with HIV

Editor's pick
Canadian HIV/AIDS Legal Network
25 April 2019
Harm reduction

New “Generic” Naloxone: Expect More Big-Pharma Sleight of Hand

Editor's pick
Filter
25 April 2019
Pharmaceutical industry

US: The Justice Department Is Looking Into Gilead’s PrEP Profits

Editor's pick
Out
25 April 2019
Access to healthcare

HIV Medical Providers Strongly Oppose Proposed Changes To Medicare Drug Plan’s “Protected Classes”

Editor's pick
Poz
25 April 2019
Experiences of stigma

No reduction in HIV stigma in San Francisco, 2011 to 2017

News
25 April 2019
Migrants, refugees & displaced people

Transgender Immigration detainee died of AIDS complications, autopsy shows

Editor's pick
CBS News
24 April 2019
Clinical trials

Why Do Study Participants Misreport Their HIV Status?

Editor's pick
The Body Pro
24 April 2019
PrEP science

PrEP May Offer Psychological Benefits to Gay, Bisexual Men at Risk for HIV

Editor's pick
American Journal of Managed Care
24 April 2019
Harm reduction

FDA OKs First Generic Naloxone Nasal Spray for Opioid Overdose

Editor's pick
Poz
24 April 2019
Hepatitis & HIV

Fatty liver disease a rising cause of liver problems in people with HIV

News
24 April 2019
People who inject drugs

Seattle HIV cluster found in drug users, those without homes

Editor's pick
San Francisco Chronicle
23 April 2019